Stefani A. Wolff
Equibles does not estimate personal net worth.
About Stefani A. Wolff
Earlier roles on record: COO at Nurix Therapeutics, Inc. (NRIX) until May 2, 2023. Nurix Therapeutics, Inc. reported in an 8-K filed April 10, 2023 that Stefani A. Wolff resigned as Chief Operating Officer and Executive Vice President of Product Development, effective May 2, 2023. The proxy statement of Nurix Therapeutics, Inc. reports total compensation of $7,148,424 for Stefani A. Wolff in fiscal 2021, including a base salary of $164,576.
“On April 5, 2023, Stefani A. Wolff notified Nurix Therapeutics, Inc. ("Nurix") of her decision to resign from her position as Chief Operating Officer and Executive Vice President of Product Development of Nurix, effective May 2, 2023.”
Affiliation history
-
Start not stated–2023-05-02
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Nurix Therapeutics, Inc. (NRIX) | Chief Operating Officer and Executive Vice President, Product Development | $164,576 | $7,148,424 |